You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 10, 2025

Drugs Containing Excipient (Inactive Ingredient) POVIDONE K25


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing POVIDONE K25 excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing POVIDONE K25 excipient

Market Dynamics and Financial Trajectory for Povidone K25

Introduction to Povidone K25

Povidone K25, a type of polyvinylpyrrolidone (PVP), is a versatile pharmaceutical excipient widely used in the formulation of various drug products. Its unique properties, such as high binding power, solubility in water and organic solvents, and ability to form complexes, make it an essential component in the pharmaceutical industry.

Market Growth Drivers

The demand for Povidone K25 is driven by several key factors:

Increasing Demand in Pharmaceutical Formulations

Povidone K25 is extensively used as a binder, stabilizer, and solubilizing agent in pharmaceutical formulations. The rise in chronic diseases such as diabetes, hypertension, cancer, and HIV has necessitated the development of more effective and patient-friendly drug formulations, thereby increasing the demand for PVP-based excipients[3][4].

Role in Disinfectants and Health Hygiene

The disinfectant properties of PVP, including Povidone K25, are crucial in reducing the risk of hospital-acquired infections (HAIs) and other diseases. This has led to an increased use of PVP-based disinfectants, contributing to the market growth[1].

COVID-19 Pandemic Impact

The COVID-19 pandemic has accelerated the demand for pharmaceutical drugs, vaccines, and disinfectants, which in turn has boosted the market for PVP, including Povidone K25[4].

Market Size and Financial Projections

The global polyvinylpyrrolidone (PVP) market, which includes Povidone K25, is expected to experience significant growth in the coming years.

  • Forecast Period: The market is projected to grow at a compound annual growth rate (CAGR) of around 6% to 6.7% from 2023 to 2030/2031[1][4].
  • Market Value: By 2031, the global PVP market is estimated to surpass $4.6 billion, while by 2030, it is expected to reach approximately $3.08 billion[1][4].

Regional Analysis

The demand for Povidone K25 is not uniform across all regions but is particularly strong in certain areas:

North America and Europe

These regions are more attractive for vendors due to their well-established pharmaceutical industries and stringent health and hygiene standards. The presence of key players such as Ashland Global, BASF SE, and others in these regions further drives the market[1].

Competitive Landscape

The market for Povidone K25 is competitive, with several key players dominating the landscape:

Key Players

  • Ashland Global Holdings Inc.
  • BASF SE
  • NIPPON SHOKUBAI CO., LTD.
  • Boai NKY Pharmaceuticals Ltd.
  • Zhangzhou HuaFu Chemical Co., Ltd.
  • JH Nanhang Life Sciences Co., Ltd.
  • Star-Tech Specialty Products Co., Ltd.
  • Dongying City Huaan Chemical Industry Co., LTD.
  • Glide Chem Private Limited[1].

These companies are involved in strategic alliances, research collaborations, and acquisitions to expand their product portfolios and enhance their market presence.

Applications and Functionalities

Povidone K25 is versatile and has numerous applications:

Pharmaceutical Formulations

It serves as a standard binder, stabilizer, thickener, and solubilizing agent. Its low viscosity and low peroxide level due to PeroXeal® packaging make it easy to process and integrate into various formulations[5].

Disinfectants and Sanitizers

Its disinfectant properties are crucial in reducing the risk of infections, making it a key component in hospital and consumer disinfectants[1].

Challenges and Regulatory Environment

Despite the growth prospects, the market for Povidone K25 faces several challenges:

Stringent Regulatory Environment

Compliance with regulatory requirements for excipient approval and usage is a significant hurdle. This demands substantial investment in research and testing, which can be a barrier to entry for smaller market players[3].

Geopolitical and Economic Factors

Geopolitical instability, climate disruption, raw material shortages, and economic uncertainty can disrupt the supply chain and manufacturing processes, affecting the market[3].

Future Outlook

The future of Povidone K25 looks promising, driven by several factors:

Personalized Medicine and Precision Therapeutics

The growing emphasis on personalized medicine and precision therapeutics will drive the demand for tailored excipient solutions, including Povidone K25, to support individualized drug formulations[3].

Innovative Excipients

The development of innovative excipients and the integration of cutting-edge technologies will continue to shape the market and drive growth[3].

Key Takeaways

  • Market Growth: The global PVP market, including Povidone K25, is expected to grow at a CAGR of 6% to 6.7% from 2023 to 2030/2031.
  • Regional Strength: North America and Europe are key regions driving the market.
  • Applications: Povidone K25 is used as a binder, stabilizer, thickener, and solubilizing agent in pharmaceutical formulations and as a disinfectant.
  • Challenges: The market faces challenges such as stringent regulatory environments and geopolitical instability.
  • Future Outlook: The market is expected to grow driven by the demand for personalized medicine and innovative excipients.

Frequently Asked Questions (FAQs)

Q: What is Povidone K25 used for in the pharmaceutical industry? A: Povidone K25 is used as a binder, stabilizer, thickener, and solubilizing agent in pharmaceutical formulations.

Q: Which regions are most attractive for Povidone K25 vendors? A: North America and Europe are the most attractive regions due to their well-established pharmaceutical industries.

Q: How does the COVID-19 pandemic impact the demand for Povidone K25? A: The pandemic has increased the demand for pharmaceutical drugs, vaccines, and disinfectants, thereby boosting the market for PVP, including Povidone K25.

Q: What are the main challenges facing the Povidone K25 market? A: The main challenges include a stringent regulatory environment, geopolitical instability, and economic uncertainty.

Q: Who are the key players in the Povidone K25 market? A: Key players include Ashland Global Holdings Inc., BASF SE, NIPPON SHOKUBAI CO., LTD., and others.

Sources:

  1. Transparency Market Research - Polyvinylpyrrolidone (PVP) Market Size, Growth Drivers - 2031
  2. ChemAnalyst - Povidone Prices, Monitor, News, Market Analysis & Demand
  3. BCC Research - Understanding the Future of Pharmaceutical Excipients
  4. Data Bridge Market Research - Polyvinylpyrrolidone (PVP) Market Size, Trends & Growth Drivers By ...
  5. BASF Pharma - Kollidon® 25 - 25KG | Povidones, Copovidones

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.